A carregar...
Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer
Successful therapeutic options remain elusive for pancreatic cancer. The exquisite sensitivity and specificity of humoral and cellular immunity may provide therapeutic approaches if antigens specific for pancreatic cancer cells can be identified. Here we characterize SAS1B (ovastacin, ASTL, astacin-...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5823626/ https://ncbi.nlm.nih.gov/pubmed/29507667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23944 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|